<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903172</url>
  </required_header>
  <id_info>
    <org_study_id>Barhan-Wysong-001</org_study_id>
    <nct_id>NCT03903172</nct_id>
  </id_info>
  <brief_title>Post-partum Non-pharmacologic Pain Management</brief_title>
  <official_title>Post-partum Non-pharmacologic Pain Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wright State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wright State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine whether use of an abdominal binder for postpartum patients after&#xD;
      vaginal delivery can effectively manage their pain and reduce the need for pharmacologic&#xD;
      analgesics. The investigators hypothesize that use of an abdominal binder will decrease&#xD;
      patient pain as reported on a visual analog scale of one to ten, and will decrease quantity&#xD;
      of pain medications given. The study will be conducted at the Berry Women's Center at Miami&#xD;
      Valley Hospital. Potential eligible participants will be approached regarding the study on&#xD;
      admission to labor and delivery. The investigators will recruit 130 participants that will be&#xD;
      randomized to two study arms, standard care and standard care plus abdominal binder with 65&#xD;
      participants in each study arm. Data will be collected prospectively while participants are&#xD;
      admitted, and through review of electronic medical records. Potential benefits of this study&#xD;
      include investigation of a cost-effective method for pain management that could improve&#xD;
      patient comfort and reduce need for medications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis Use of an abdominal binder postpartum after a vaginal delivery will be associated&#xD;
      with lower pain scores and reduced need for pharmacologic analgesics.&#xD;
&#xD;
      Background A significant part of postpartum care involves management of patients' pain and&#xD;
      discomfort. Etiologies of this pain include perineal pain, incisional pain, uterine&#xD;
      involution pain, and pelvic girdle and lower back pain. Postpartum pain management primarily&#xD;
      focuses on the former three types of pain: perineal, incisional and uterine involution. In a&#xD;
      review of the management of postpartum pain, Eshkevari et al discuss several well-established&#xD;
      pain management strategies employed for postpartum patients, including ibuprofen and other&#xD;
      NSAIDs for uterine involution pain and inflammation; local anesthetics for perineal&#xD;
      lacerations or episiotomies; warm or cold compresses for perineal pain; and opioids for&#xD;
      post-operative or poorly controlled postpartum pain.&#xD;
&#xD;
      Data regarding management of pelvic girdle and lower back pain is scarce and the limited&#xD;
      literature available primarily focus on the pregnant patient. Different proposed treatment or&#xD;
      management strategies during pregnancy include physical therapy, targeted exercises,&#xD;
      acupuncture, NSAIDS and opioids. Approximately 25% of postpartum women endorse pelvic girdle&#xD;
      and/or lower back pain, and these types of pain can persist for as long as several weeks to&#xD;
      1-2 years after delivery. Therefore, management remains key for the postpartum patient as&#xD;
      well. The proposed pathophysiology behind pelvic girdle pain and lower back pain in the&#xD;
      context of pregnancy is widening of the pubic symphysis and increased laxity in the&#xD;
      sacro-iliac joints (SIJ) secondary to both biomechanical shear forces of increased weight&#xD;
      bearing and elevated levels of relaxin, a polypeptide hormone that increase laxity of&#xD;
      ligaments. A prospective study investigating the impact of abdomino-pelvic belts at different&#xD;
      positions on the laxity of the SIJ found that use of the abdomino-pelvic belt significantly&#xD;
      decreased mobility of the SIJ. Additionally, pelvic belts or abdominal binders may help&#xD;
      provide stability to muscles of the abdomen, back and spine.&#xD;
&#xD;
      Studies investigating the use of abdominal binders for pain management in post-operative&#xD;
      patients following both cesarean section and gynecologic surgery have had mixed results. A&#xD;
      randomized control trial examining impact of abdominal binders on patient reported pain and&#xD;
      symptom distress found no significant difference in pain on post-operative days one and two,&#xD;
      and the difference in distress on post-operative day two was no longer statistically&#xD;
      significant after correction for multiple measures. Another study involving gynecologic&#xD;
      surgery patients randomized to abdominal binder or control groups found that there was no&#xD;
      overall significant difference in morphine use or pain scale between the groups, and the&#xD;
      benefits were limited to a significant effect on post-operative ambulation for a subset of&#xD;
      patients with highest risk of complications: patients &gt; 50 years, cancer patients, and those&#xD;
      with vertical incision. In contrast, a more recent randomized controlled trial assessing&#xD;
      abdominal binders following cesarean delivery found that pain and symptom distress scores&#xD;
      were significantly lower at all time points in comparison to a control group.&#xD;
&#xD;
      A common theme in the current literature regarding postpartum pain management is the need for&#xD;
      more research. In light of the current opioid abuse epidemic, which affects approximately 2.1&#xD;
      million people and the U.S Department of Health and Human Services declared a public health&#xD;
      emergency in 2017, there is a renewed emphasis utilizing non-opioid methods on pain control.&#xD;
      As a primary source of pain in the postpartum period is associated with musculoskeletal&#xD;
      pelvic discomfort, the use of a supportive abdomino-pelvic belt may be a non-pharmacologic&#xD;
      modality that could reduce pain and decrease narcotic requirements in postpartum patients. No&#xD;
      studies have directly assessed the effectiveness of abdominal binders on pain management in&#xD;
      postpartum patients. This study aims to examine how use of an abdominal binder might impact&#xD;
      postpartum pain, and the use of pharmacologic analgesia following vaginal delivery.&#xD;
&#xD;
      Protocol&#xD;
&#xD;
        -  Recruitment&#xD;
&#xD;
           o Patients admitted to Labor and Delivery will be evaluated for potential participation&#xD;
           in the study based on the inclusion and exclusion criteria outlined below. If&#xD;
           appropriate to approach, eligible potential participants will be approached in their&#xD;
           labor and delivery room prior to delivery. If interested in participation, the Informed&#xD;
           Consent document will be presented and explained in the room to ensure privacy.&#xD;
&#xD;
        -  Subject Informed Consent&#xD;
&#xD;
             -  Informed consent process will take place at the Berry Women's Center at Miami&#xD;
                Valley Hospital&#xD;
&#xD;
             -  Written and signed consent will be obtained in English.&#xD;
&#xD;
        -  Plans of obtaining informed consent:&#xD;
&#xD;
           o Potential eligible participants will be approached in the labor and delivery room to&#xD;
           ensure privacy. The research assistant will provide and discuss an informed consent form&#xD;
           with the participant. The informed consent form will describe the project goals, length&#xD;
           and rational, as well as the types of PHI that will be collected. All participants who&#xD;
           agree to participate in the study will sign the informed consent form. All participants&#xD;
           will be provided with a copy of the signed consent form.&#xD;
&#xD;
        -  Study design and procedures&#xD;
&#xD;
             -  After signing informed consent, participants will be assigned to the intervention&#xD;
                or control group via block randomization&#xD;
&#xD;
             -  Those participants in the standard of care group will receive routine postpartum&#xD;
                care&#xD;
&#xD;
             -  Those participants in the intervention group will receive an abdominal binder in&#xD;
                addition to routine postpartum care&#xD;
&#xD;
             -  Determination of appropriate binder size will be based on a visual assessment of&#xD;
                the patient's abdominal circumference&#xD;
&#xD;
             -  Nursing staff will evaluate participant's pain level using a visual analog scale of&#xD;
                1-10 a minimum of every 4 hours. Patient reported pain score and pain location will&#xD;
                be recorded in the participant's electronic medical record. These processes do not&#xD;
                deviate from current standards of care and documentation.&#xD;
&#xD;
             -  Additional non-pharmacologic pain relief measures utilized by patients will be&#xD;
                documented on the data collection sheet attached to the patient's chart. These&#xD;
                measures include heating pad, ice pack, and tucks pads&#xD;
&#xD;
             -  All medications received will be documented in the electronic medical record per&#xD;
                usual documentation protocols&#xD;
&#xD;
        -  Sample Size Estimation &amp; Data Analysis Plan&#xD;
&#xD;
             -  Sample size was estimated using G*Power. In order to detect a difference between&#xD;
                groups on pain scores and use of pain medications, 65 patients per group will need&#xD;
                to be enrolled. This will enable the investigators to detect a moderate difference&#xD;
                (i.e., medium effect size) between the groups with a power = 80% and p at &lt;0.05.&#xD;
&#xD;
             -  The two groups will be compared for 1. reported pain scores (assessed by nursing&#xD;
                staff and documented in the EMR) and for 2. pain medications used (morphine&#xD;
                equivalent as recorded in the MAR) for the duration of patients' hospital stay.&#xD;
                T-test will be used to compare the groups on average pain scores and total pain&#xD;
                medication use. Repeated measures analysis of variance will be used to determine&#xD;
                differences between the groups over time.&#xD;
&#xD;
        -  Data collection plan&#xD;
&#xD;
             -  Prospective data collection with hard copy data entry form that includes PHI for&#xD;
                participant identification, basic demographic information, delivery information&#xD;
                (see separate document), non-pharmacologic pain relief measures used&#xD;
&#xD;
             -  Electronic medical record review for: pain scores, pain location, medications&#xD;
                received&#xD;
&#xD;
             -  Pain score immediately postpartum&#xD;
&#xD;
             -  Pain scores (average scores) on PPD#0 and PPD#1&#xD;
&#xD;
             -  Patient reported pain locations&#xD;
&#xD;
             -  Quantity (total) of non-narcotic pain medication received on PPD#0 and PPD#1&#xD;
&#xD;
             -  Quantity (total) of narcotic pain medication received on PPD#0 and PPD#1&#xD;
&#xD;
        -  Risks&#xD;
&#xD;
             -  Allergic reaction to fabric of abdominal binder&#xD;
&#xD;
             -  Skin irritation&#xD;
&#xD;
             -  Increased discomfort or pain with use of abdominal binder&#xD;
&#xD;
        -  Mitigation of risks o If participants experience an allergic reaction or skin irritation&#xD;
           from the abdominal binder symptomatic treatment will be offered. Participants in the&#xD;
           experimental arm will be encouraged to keep the abdominal binders in place for 24 hours&#xD;
           postpartum, but will be permitted to remove the abdominal binder at any time should it&#xD;
           cause irritation, increased pain or any other adverse reaction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Non-blinded, parallel group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patient reported average pain score</measure>
    <time_frame>Average score computed from Immediately postpartum, postpartum day 0, postpartum day 1</time_frame>
    <description>Pain score (standard scale is 1 - no pain to 10- severe pain) will be recorded by nursing staff in electronic medical record per standard of care. Average pain score for postpartum day 0 and postpartum day 1 will be computed. High scores represent greater pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total non-narcotic pain medication use</measure>
    <time_frame>Total non-narcotic medication use from sum of postpartum day 0 and postpartum day 1</time_frame>
    <description>Total non-narcotic pain medication use recorded on MAR for postpartum day 0 and postpartum day 1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total narcotic pain medication use</measure>
    <time_frame>Total narcotic medication use from sum of postpartum day 0 and postpartum day 1</time_frame>
    <description>Total narcotic pain medication use (in morphine equivalents) as recorded on MAR for postpartum day 0 and postpartum day 1</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Pain Management</condition>
  <condition>Vaginal Delivery</condition>
  <arm_group>
    <arm_group_label>Binder Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abdominal binder + standard of care postpartum pain management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care postpartum pain managment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abdominal binder</intervention_name>
    <description>Abdominal binder</description>
    <arm_group_label>Binder Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age and older&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Admitted to labor and delivery&#xD;
&#xD;
          -  Anticipated spontaneous vaginal delivery&#xD;
&#xD;
          -  Informed consent obtained&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented chronic pain condition&#xD;
&#xD;
          -  Chronic narcotic use or Maternal Abstinence Treatment&#xD;
&#xD;
          -  UDS positive for opiates on admission&#xD;
&#xD;
          -  Trial of labor after cesarean&#xD;
&#xD;
          -  Lack of sufficient English proficiency to obtain informed consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women will be enrolled</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheela Barhan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wright State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Miami Valley Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.hhs.gov/opioids/about-the-epidemic/index.html</url>
    <description>HHS &quot;About the Epidemic&quot;</description>
  </link>
  <reference>
    <citation>Eshkevari L, Trout KK, Damore J. Management of postpartum pain. J Midwifery Womens Health. 2013 Nov-Dec;58(6):622-31. doi: 10.1111/jmwh.12129. Review.</citation>
    <PMID>24406035</PMID>
  </reference>
  <reference>
    <citation>Wu WH, Meijer OG, Uegaki K, Mens JM, van DieÃ«n JH, Wuisman PI, Ostgaard HC. Pregnancy-related pelvic girdle pain (PPP), I: Terminology, clinical presentation, and prevalence. Eur Spine J. 2004 Nov;13(7):575-89. Epub 2004 Aug 27. Review.</citation>
    <PMID>15338362</PMID>
  </reference>
  <reference>
    <citation>Vermani E, Mittal R, Weeks A. Pelvic girdle pain and low back pain in pregnancy: a review. Pain Pract. 2010 Jan-Feb;10(1):60-71. doi: 10.1111/j.1533-2500.2009.00327.x. Epub 2010 Oct 26. Review.</citation>
    <PMID>19863747</PMID>
  </reference>
  <reference>
    <citation>Mens JM, Damen L, Snijders CJ, Stam HJ. The mechanical effect of a pelvic belt in patients with pregnancy-related pelvic pain. Clin Biomech (Bristol, Avon). 2006 Feb;21(2):122-7. Epub 2005 Oct 7.</citation>
    <PMID>16214275</PMID>
  </reference>
  <reference>
    <citation>Liddle SD, Pennick V. Interventions for preventing and treating low-back and pelvic pain during pregnancy. Cochrane Database Syst Rev. 2015 Sep 30;(9):CD001139. doi: 10.1002/14651858.CD001139.pub4. Review.</citation>
    <PMID>26422811</PMID>
  </reference>
  <reference>
    <citation>Gillier CM, Sparks JR, Kriner R, Anasti JN. A randomized controlled trial of abdominal binders for the management of postoperative pain and distress after cesarean delivery. Int J Gynaecol Obstet. 2016 May;133(2):188-91. doi: 10.1016/j.ijgo.2015.08.026. Epub 2016 Jan 14.</citation>
    <PMID>26892694</PMID>
  </reference>
  <reference>
    <citation>Ghana S, Hakimi S, Mirghafourvand M, Abbasalizadeh F, Behnampour N. Randomized controlled trial of abdominal binders for postoperative pain, distress, and blood loss after cesarean delivery. Int J Gynaecol Obstet. 2017 Jun;137(3):271-276. doi: 10.1002/ijgo.12134. Epub 2017 Mar 28.</citation>
    <PMID>28241386</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wright State University</investigator_affiliation>
    <investigator_full_name>Sheela Barhan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pain management</keyword>
  <keyword>vaginal delivery</keyword>
  <keyword>nonpharmacologic</keyword>
  <keyword>abdominal binder</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be shard on a case by case basis.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

